CMMB

Chemomab Therapeutics Ltd. - ADR

1.77

USD

CMMB Earnings Reports

Positive Surprise Ratio

CMMB beat 3 of 20 last estimates.

15%

Next Report

Date of Next Report

Mar 02, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.01

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

-98.44%

Chemomab Therapeutics Ltd. - ADR earnings per share and revenue

On Nov 17, 2025, CMMB reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.01 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Chemomab Therapeutics Ltd. - ADR's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Chemomab Therapeutics Ltd. - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Chemomab Therapeutics Ltd. - ADR's Q3 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Chemomab Therapeutics Ltd. - ADR expected to report next?

The next earning report is scheduled for Mar 02, 2026.

What are the forecasts for Chemomab Therapeutics Ltd. - ADR's next earnings report?

Based on 3 analysts, Chemomab Therapeutics Ltd. - ADR is expected to report EPS of -$0.01 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.